[HTML][HTML] Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases
C Rolin, J Zimmer, C Seguin-Devaux - Cellular & Molecular …, 2024 - nature.com
By binding to multiple antigens simultaneously, multispecific antibodies are expected to
substantially improve both the activity and long-term efficacy of antibody-based …
substantially improve both the activity and long-term efficacy of antibody-based …
[HTML][HTML] Current perspectives of viral hepatitis
D Usuda, Y Kaneoka, R Ono, M Kato… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Viral hepatitis represents a major danger to public health, and is a globally leading cause of
death. The five liver-specific viruses: Hepatitis A virus, hepatitis B virus, hepatitis C virus …
death. The five liver-specific viruses: Hepatitis A virus, hepatitis B virus, hepatitis C virus …
[HTML][HTML] Current trends and advances in antiviral therapy for chronic hepatitis B
J Li, S Liu, Q Zang, R Yang, Y Zhao… - Chinese Medical …, 2024 - journals.lww.com
Chronic hepatitis B virus (HBV) infection is a global public health concern. Existing antiviral
drugs, including nucleos (t) ide analogs and interferon-α, can suppress HBV replication and …
drugs, including nucleos (t) ide analogs and interferon-α, can suppress HBV replication and …
A critical review of the prospects and challenges of Hepatitis B therapeutic vaccines
Hepatitis B therapeutic vaccines hold great promise in the treatment of chronic Hepatitis B
virus (HBV) infection. However, like any medical intervention, they also face certain …
virus (HBV) infection. However, like any medical intervention, they also face certain …